ArticleInternational journal of molecular sciences2024

Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report.

Donato Michele Cosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.